• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Certolizumab pegol as an alternative treatment in patients with coexisting hidradenitis suppurativa and other inflammatory immune-mediated diseases: Report of two cases.

作者信息

Melgosa Ramos Francisco Javier, García Ruiz Ramón, Mateu Puchades Almudena

机构信息

Department of Dermatology, University Hospital Doctor Peset, Valencia, Spain.

出版信息

Dermatol Ther. 2022 May;35(5):e15401. doi: 10.1111/dth.15401. Epub 2022 Mar 1.

DOI:10.1111/dth.15401
PMID:35199899
Abstract
摘要

相似文献

1
Certolizumab pegol as an alternative treatment in patients with coexisting hidradenitis suppurativa and other inflammatory immune-mediated diseases: Report of two cases.聚乙二醇化赛妥珠单抗作为化脓性汗腺炎合并其他炎症性免疫介导疾病患者的替代治疗：两例报告
Dermatol Ther. 2022 May;35(5):e15401. doi: 10.1111/dth.15401. Epub 2022 Mar 1.
2
Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.病例报告：采用不同治疗方法治疗化脓性汗腺炎和银屑病共存。
F1000Res. 2019 Nov 26;8:2002. doi: 10.12688/f1000research.21216.2. eCollection 2019.
3
Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa.聚乙二醇化赛妥珠单抗及其在育龄期化脓性汗腺炎中的作用。
Int J Dermatol. 2022 May;61(5):e182-e184. doi: 10.1111/ijd.15742. Epub 2021 Jul 16.
4
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.聚乙二醇化赛妥珠单抗治疗化脓性汗腺炎：病例报告及文献综述
Dermatol Ther. 2020 Nov;33(6):e14494. doi: 10.1111/dth.14494. Epub 2020 Nov 16.
5
Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy.孕期使用赛妥珠单抗治疗化脓性汗腺炎。
Int J Dermatol. 2021 Apr;60(4):e140-e141. doi: 10.1111/ijd.15286. Epub 2020 Nov 28.
6
The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.前沿。用阿达木单抗治疗重度化脓性汗腺炎。
Arch Dermatol. 2006 Sep;142(9):1110-2. doi: 10.1001/archderm.142.9.1110.
7
Golimumab, as an alternative treatment in patients with coexisting hidradenitis suppurativa and arthritis after adalimumab failure: Report of two cases.戈利木单抗在阿达木单抗治疗失败后合并化脓性汗腺炎和关节炎患者中的替代治疗：两例报告。
Dermatol Ther. 2022 Mar;35(3):e15266. doi: 10.1111/dth.15266. Epub 2021 Dec 30.
8
Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.司库奇尤单抗可能是治疗化脓性汗腺炎继发系统性淀粉样变的方法。
Dermatol Ther. 2020 Nov;33(6):e14205. doi: 10.1111/dth.14205. Epub 2020 Sep 11.
9
Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis.培戈洛珠单抗：中重度斑块状银屑病治疗药物。
BioDrugs. 2020 Apr;34(2):235-244. doi: 10.1007/s40259-020-00416-z.
10
Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.用阿达木单抗治疗重度顽固性化脓性汗腺炎。
J Dtsch Dermatol Ges. 2009 Feb;7(2):139-41. doi: 10.1111/j.1610-0387.2008.06918.x.

引用本文的文献

1
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation.妊娠和哺乳期化脓性汗腺炎管理指南
Am J Clin Dermatol. 2025 May;26(3):345-360. doi: 10.1007/s40257-025-00935-x. Epub 2025 Mar 25.
2
Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments.化脓性汗腺炎：生物制剂和小分子免疫调节治疗综述
J Cutan Med Surg. 2025 Jan-Feb;29(1):NP1-NP20. doi: 10.1177/12034754241300292. Epub 2024 Nov 27.
3
Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective.
戈利木单抗和聚乙二醇化赛妥珠单抗治疗化脓性汗腺炎：文献综述与未来展望
Ther Adv Chronic Dis. 2024 May 31;15:20406223241257342. doi: 10.1177/20406223241257342. eCollection 2024.
4
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies.化脓性汗腺炎的新兴治疗方法及临床试验概况 第一部分：局部和全身药物治疗
Dermatol Ther (Heidelb). 2023 Aug;13(8):1661-1697. doi: 10.1007/s13555-023-00956-6. Epub 2023 Jul 4.
5
Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.免疫调节药物治疗化脓性汗腺炎：可能性与局限性。
Int J Mol Sci. 2022 Aug 26;23(17):9716. doi: 10.3390/ijms23179716.